{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:48:48Z","timestamp":1792406928279,"version":"4.4.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ogx.0b013e3182732375","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T06:38:20Z","timestamp":1351665500000},"page":"658-667","source":"Crossref","is-referenced-by-count":24,"title":["Cervical Cancer Screening in High- and Low-Resource Countries"],"prefix":"10.1097","volume":"67","author":[{"given":"Claire","family":"Hoppenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Stampler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-24-20210212","doi-asserted-by":"crossref","first-page":"M89","DOI":"10.1016\/j.vaccine.2008.06.020","article-title":". Recommendations for cervical cancer prevention in Asia Pacific. ICO Monograph Series on HPV and Cervical Cancer: Asia Pacific Regional Report.","volume":"26S","author":"Garland","year":"2008","journal-title":"Vaccine"},{"key":"R3-24-20210212","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":". Cost-effectiveness of cervical-cancer screening in five developing countries.","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-24-20210212","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":". Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.","volume":"26S","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"R5-24-20210212","first-page":"313","article-title":"Cervical cancer screening in the 21st century: is it time to retire the Pap smear Clin Obstet Gynecol.","volume":"50","author":"Wright","year":"2007","journal-title":""},{"key":"R6-24-20210212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ijc.25974","article-title":". Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.","volume":"129","author":"Gravitt","year":"2011","journal-title":"Int J Cancer"},{"key":"R7-24-20210212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.11726","article-title":". Initial results from a randomized trial of cervical visual screening in rural south India.","volume":"109","author":"Sankaranarayanan","year":"2004","journal-title":"Int J Cancer"},{"key":"R8-24-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13510","article-title":". ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"key":"R9-24-20210212","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijgo.2005.01.009","article-title":". A critical assessment of screening methods for cervical neoplasia.","volume":"89","author":"Sankaranarayanan","year":"2005","journal-title":"Int J Gynecol Obstet"},{"key":"R11-24-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.23489","article-title":". Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.","volume":"123","author":"Arbyn","year":"2008","journal-title":"Int J Cancer"},{"key":"R12-24-20210212","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/ijc.21972","article-title":". Visual inspection as cervical cancer screening in a primary health care setting in Africa.","volume":"119","author":"Sangwa-Lugoma","year":"2006","journal-title":"Int J Cancer"},{"key":"R13-24-20210212","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(10)70256-4","article-title":". Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.","volume":"11","author":"Zhao","year":"2010","journal-title":"Lancet Oncol"},{"key":"R14-24-20210212","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/520022","article-title":"Cervical cancer screening of women living with HIV infection; a must in the era of antiretroviral therapy.","volume":"45","author":"Franceschi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R15-24-20210212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/msj.20263","article-title":". Cervical cancer screening in low- and middle-income countries.","volume":"78","author":"Ditzina","year":"2011","journal-title":"Mt Sinai J Med"},{"key":"R16-24-20210212","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/ijc.25150","article-title":". Cost-effectiveness analysis of cervical cancer prevention based on rapid human papillomavirus screening test in a high-risk region of China.","volume":"127","author":"Levin","year":"2010","journal-title":"Int J Cancer"},{"key":"R17-24-20210212","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/ijc.25915","article-title":". EUROGIN 2010 roadmap on cervical cancer prevention.","volume":"128","author":"Franceschi","year":"2011","journal-title":"Int J Cancer"},{"key":"R18-24-20210212","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ijc.20190","article-title":". Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa.","volume":"110","author":"Sankarnarayanan","year":"2004","journal-title":"Int J Cancer"},{"key":"R20-24-20210212","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(07)61195-7","article-title":". Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.","volume":"370","author":"Sankaranarayanan","year":"2007","journal-title":"Lancet"},{"key":"R21-24-20210212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJMoa0808516","article-title":". HPV Screening for cervical cancer in rural India.","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"R22-24-20210212","first-page":"305","article-title":"HPV screening for cervical cancer in rural India.","volume":"361","author":"Mwanahamuntu","year":"2009","journal-title":"N Engl J Med"},{"key":"R23-24-20210212","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":". Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"R24-24-20210212","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":". Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"R25-24-20210212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":". Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R26-24-20210212","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":". A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"key":"R27-24-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2<206::AID-IJC10>3.0.CO;2-Q","article-title":". HPV-based cervical cancer screening in a population at high risk for HIV infection.","volume":"85","author":"Womack","year":"2000","journal-title":"Int J Cancer"},{"key":"R28-24-20210212","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":". Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBSCAM randomised controlled trial.","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"R29-24-20210212","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.25731","article-title":". A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat.","volume":"129","author":"Taylor","year":"2010","journal-title":"Int J Cancer"},{"key":"R31-24-20210212","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","article-title":". Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.","volume":"93","author":"Kotanimei-Talonen","year":"2005","journal-title":"Br J Cancer"},{"key":"R32-24-20210212","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/djq342","article-title":". Human Papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.","volume":"102","author":"Denny","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R33-24-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.18553\/jmcp.2010.16.3.217","article-title":"A review of the cost-effectiveness of vaccination against oncogenic HPV types.","volume":"16","author":"Armstrong","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"R34-24-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0266462309090217","article-title":". Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.","volume":"25","author":"Thiry","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"key":"R35-24-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-5-8","article-title":"The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research.","volume":"5","author":"Bratcher","year":"2010","journal-title":"Infect Agents Cancer"},{"key":"R36-24-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/gyno.1998.4938","article-title":". Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus.","volume":"68","author":"Maiman","year":"1998","journal-title":"Gynecol Oncol"},{"key":"R37-24-20210212","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM199711063371903","article-title":". Human papillomavirus infection in women infected with the human immunodeficiency virus.","volume":"337","author":"Sun","year":"1997","journal-title":"N Engl J Med"},{"key":"R38-24-20210212","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/ijc.2910570612","article-title":". Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions.","volume":"57","author":"Petry","year":"1994","journal-title":"Int J Cancer"},{"key":"R39-24-20210212","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/QAD.0b013e32833e163e","article-title":". Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV infected women.","volume":"24","author":"Kuhn","year":"2010","journal-title":"AIDS"},{"key":"R41-24-20210212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e328340fd99","article-title":". Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.","volume":"25","author":"Omar","year":"2011","journal-title":"AIDS"},{"key":"R42-24-20210212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/COH.0b013e328319bcbe","article-title":"Prevention of cervical cancer in women with HIV.","volume":"4","author":"Heard","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"R43-24-20210212","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpobgyn.2004.10.002","article-title":"HIV and cancer of the cervix.","volume":"19","author":"Chirenje","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R44-24-20210212","doi-asserted-by":"crossref","first-page":"N1","DOI":"10.1097\/QAD.0b013e3283236e11","article-title":". Implementation of see-and-treat cervical cancer prevention services linked to HIV care in Zambia.","volume":"23","author":"Mwanahamuntu","year":"2009","journal-title":"AIDS"}],"container-title":["Obstetrical &amp; Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006254-201210000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:33:54Z","timestamp":1618036434000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-201210000-00024"}},"subtitle":["Implications and New Developments"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e3182732375","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}